Powers Martin P, Alvarez Karla, Kim Hyun-Jung, Monzon Federico A
Department of Pathology and Laboratory Medicine, The Methodist Hospital and The Methodist Hospital Research Institute, Houston, TX, USA.
Diagn Mol Pathol. 2011 Jun;20(2):63-70. doi: 10.1097/PDM.0b013e3181efe2a9.
Oncocytoma, chromophobe renal cell carcinoma (chRCC), and the eosinophilic variant of clear cell RCC (ccRCC) are morphologically similar tumors with significantly different clinical courses. These renal tumor subtypes show characteristic structural genetic changes; however, the mRNA expression patterns of oncocytoma and chRCC are strikingly similar. MicroRNAs (miRNA) are small RNA molecules that regulate the expression of many genes and have been shown to be useful for tumor classification and identification. The miRNA expression was analyzed from formalin-fixed paraffin-embedded tissue in 5 cases each of oncocytoma, ccRCC, papillary RCC, chRCC, and 4 normal kidney tissues using microarrays. Affymetrix single-nucleotide polymorphism arrays were used to detect chromosomal imbalances in each of the tumors. Eighteen miRNAs were significantly different among the 4 tumor types. The microRNA miR-21, a known oncogenic miRNA, was found to be upregulated in papillary and clear cell carcinomas. Four miRNAs could differentiate oncocytomas from chRCCs and the 3 could differentiate papillary RCC from ccRCC, including miR-126, a known vasculogenic miRNA. Of the 18 differentially expressed miRNAs, only 2 correlated with copy number changes in the chromosomal region harboring these genes. One tumor, originally diagnosed as an oncocytoma by morphology, showed a virtual karyotype and miRNA expression pattern consistent with chromophobe carcinoma. Further investigation of the tumor showed vascular invasion. Our study suggests that miRNA expression can be used to differentiate the common subtypes of renal epithelial neoplasms but further validation is necessary. In addition, the lack of correlation between miRNA expression and virtual karyotype suggests a non-copy-number-related mechanism for miRNA gene expression regulation in renal neoplasia.
嗜酸细胞瘤、嫌色性肾细胞癌(chRCC)和透明细胞肾细胞癌(ccRCC)的嗜酸性变体是形态学上相似但临床病程显著不同的肿瘤。这些肾肿瘤亚型表现出特征性的结构基因改变;然而,嗜酸细胞瘤和chRCC的mRNA表达模式惊人地相似。微小RNA(miRNA)是调节许多基因表达的小RNA分子,已被证明可用于肿瘤分类和鉴定。使用微阵列分析了5例嗜酸细胞瘤、ccRCC、乳头状肾细胞癌、chRCC的福尔马林固定石蜡包埋组织以及4例正常肾组织中的miRNA表达。使用Affymetrix单核苷酸多态性阵列检测每种肿瘤中的染色体失衡。在这4种肿瘤类型中,有18种miRNA存在显著差异。已知的致癌miRNA miR-21在乳头状癌和透明细胞癌中上调。4种miRNA可区分嗜酸细胞瘤和chRCC,3种可区分乳头状肾细胞癌和ccRCC,包括已知的血管生成miRNA miR-126。在18种差异表达的miRNA中,只有2种与这些基因所在染色体区域的拷贝数变化相关。1例最初通过形态学诊断为嗜酸细胞瘤的肿瘤,其虚拟核型和miRNA表达模式与嫌色性癌一致。对该肿瘤的进一步检查显示有血管侵犯。我们的研究表明,miRNA表达可用于区分肾上皮肿瘤的常见亚型,但需要进一步验证。此外,miRNA表达与虚拟核型之间缺乏相关性,提示肾肿瘤中miRNA基因表达调控存在非拷贝数相关机制。